TY - JOUR
T1 - Causal relevance of blood lipid fractions in the development of carotid atherosclerosis mendelian randomization analysis
AU - Shah, Sonia
AU - Casas, Juan Pablo
AU - Drenos, Fotios
AU - Whittaker, John
AU - Deanfield, John
AU - Swerdlow, Daniel I.
AU - Holmes, Michael V.
AU - Kivimaki, Mika
AU - Langenberg, Claudia
AU - Wareham, Nick
AU - Gertow, Karl
AU - Sennblad, Bengt
AU - Strawbridge, Rona J.
AU - Baldassarre, Damiano
AU - Veglia, Fabrizio
AU - Tremoli, Elena
AU - Gigante, Bruna
AU - De Faire, Ulf
AU - Kumari, Meena
AU - Talmud, Philippa J.
AU - Hamsten, Anders
AU - Humphries, Steve E.
AU - Hingorani, Aroon D.
PY - 2013/2
Y1 - 2013/2
N2 - Background-Carotid intima-media thickness (CIMT), a subclinical measure of atherosclerosis, is associated with risk of coronary heart disease events. Statins reduce progression of CIMT and coronary heart disease risk in proportion to the reduction in low-density lipoprotein cholesterol. However, interventions targeting triglycerides (TGs) or high-density lipoprotein cholesterol (HDL-C) have produced inconsistent effects on CIMT and coronary heart disease risk, making it uncertain whether such agents are ineffective for coronary heart disease prevention or whether CIMT is an inadequate marker of HDL-C or TG-mediated effects. We aimed to determine the causal association among the 3 major blood lipid fractions and common CIMT using mendelian randomization analysis. Methods and Results-Genetic scores specific for low-density lipoprotein cholesterol, HDL-C, and TGs were derived based on single nucleotide polymorphisms from a gene-centric array in ≈5000 individuals (Cardiochip scores) and from a genome-wide association meta-analysis in >100 000 individuals (Global Lipids Genetic Consortium scores). These were used as instruments in a mendelian randomization analysis in 2 prospective cohort studies. A genetically predicted 1 mmol/L higher low-density lipoprotein cholesterol concentration was associated with a higher common CIMT by 0.03 mm (95% confidence interval, 0.01-0.04) and 0.04 mm (95% confidence interval, 0.02-0.06) based on the Cardiochip and Global Lipids Genetic Consortium scores, respectively. HDL-C and TGs were not causally associated with CIMT. Conclusions-Our findings confirm a causal relationship between low-density lipoprotein cholesterol and CIMT but not with HDL-C and TGs. At present, the suitability of CIMT as a surrogate marker in trials of cardiovascular therapies targeting HDL-C and TGs is questionable and requires further study.
AB - Background-Carotid intima-media thickness (CIMT), a subclinical measure of atherosclerosis, is associated with risk of coronary heart disease events. Statins reduce progression of CIMT and coronary heart disease risk in proportion to the reduction in low-density lipoprotein cholesterol. However, interventions targeting triglycerides (TGs) or high-density lipoprotein cholesterol (HDL-C) have produced inconsistent effects on CIMT and coronary heart disease risk, making it uncertain whether such agents are ineffective for coronary heart disease prevention or whether CIMT is an inadequate marker of HDL-C or TG-mediated effects. We aimed to determine the causal association among the 3 major blood lipid fractions and common CIMT using mendelian randomization analysis. Methods and Results-Genetic scores specific for low-density lipoprotein cholesterol, HDL-C, and TGs were derived based on single nucleotide polymorphisms from a gene-centric array in ≈5000 individuals (Cardiochip scores) and from a genome-wide association meta-analysis in >100 000 individuals (Global Lipids Genetic Consortium scores). These were used as instruments in a mendelian randomization analysis in 2 prospective cohort studies. A genetically predicted 1 mmol/L higher low-density lipoprotein cholesterol concentration was associated with a higher common CIMT by 0.03 mm (95% confidence interval, 0.01-0.04) and 0.04 mm (95% confidence interval, 0.02-0.06) based on the Cardiochip and Global Lipids Genetic Consortium scores, respectively. HDL-C and TGs were not causally associated with CIMT. Conclusions-Our findings confirm a causal relationship between low-density lipoprotein cholesterol and CIMT but not with HDL-C and TGs. At present, the suitability of CIMT as a surrogate marker in trials of cardiovascular therapies targeting HDL-C and TGs is questionable and requires further study.
KW - Carotid intima-media thickness
KW - Lipids
KW - Mendelian randomization
UR - http://www.scopus.com/inward/record.url?scp=84878042322&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878042322&partnerID=8YFLogxK
U2 - 10.1161/CIRCGENETICS.112.963140
DO - 10.1161/CIRCGENETICS.112.963140
M3 - Article
C2 - 23275344
AN - SCOPUS:84878042322
SN - 1942-3268
VL - 6
SP - 63
EP - 72
JO - Circulation: Cardiovascular Genetics
JF - Circulation: Cardiovascular Genetics
IS - 1
ER -